Javascript must be enabled to continue!
Downregulation of NOTCH1 and NOTCH4 signalling influences the modulation of schizophrenia onset
View through CrossRef
Background
Schizophrenia is a chronic neuropsychiatric disorder characterised by a range of positive and negative symptoms. The genetic aspect of schizophrenia is highly pleiotropic, as the complete set of neurodevelopmental factors contributing to the onset of the disease has yet to be fully identified. The Notch signalling pathway is increasingly recognised as a key player in the neurodevelopmental processes, where disruptions in the signalling may be linked to the development of schizophrenia. This study aims to evaluate the expression pattern of NOTCH1 and NOTCH4 at gene and protein levels among schizophrenia cases while considering lifestyle parameters as potential risk factors.
Methods
For this study, data were collected from 75 diagnosed schizophrenia patients and 75 healthy controls through a face-to-face interview. Peripheral whole blood was collected from all the cases and control individuals in the hospital set-up after obtaining proper consent. The gene expression study was conducted using quantitative reverse transcription-PCR, and serum level expression was studied using enzyme linked immunosorbent assay. Finally, statistical analysis was performed using Jamovi software.
Results
In the present study, the mean age of schizophrenia cases was found to be 31.5 (±10.4) years. Among the cases, the majority (45.3%, n = 34) were aged 20–29 years. Results revealed that NOTCH1 and NOTCH4 expression were significantly reduced in schizophrenia cases compared with healthy controls, both in mRNA and serum protein levels. Further, NOTCH4 expression was significantly reduced in those cases with a chronic mental illness, compared with those without chronic past mental illness.
Conclusion
The findings showed downregulation of NOTCH1 and NOTCH4 in schizophrenia. Moreover, significant reduction of NOTCH4 gene expression in cases with persistent mental illness, highlighting its possible role in the pathophysiology of the disease.
Ovid Technologies (Wolters Kluwer Health)
Title: Downregulation of NOTCH1 and NOTCH4 signalling influences the modulation of schizophrenia onset
Description:
Background
Schizophrenia is a chronic neuropsychiatric disorder characterised by a range of positive and negative symptoms.
The genetic aspect of schizophrenia is highly pleiotropic, as the complete set of neurodevelopmental factors contributing to the onset of the disease has yet to be fully identified.
The Notch signalling pathway is increasingly recognised as a key player in the neurodevelopmental processes, where disruptions in the signalling may be linked to the development of schizophrenia.
This study aims to evaluate the expression pattern of NOTCH1 and NOTCH4 at gene and protein levels among schizophrenia cases while considering lifestyle parameters as potential risk factors.
Methods
For this study, data were collected from 75 diagnosed schizophrenia patients and 75 healthy controls through a face-to-face interview.
Peripheral whole blood was collected from all the cases and control individuals in the hospital set-up after obtaining proper consent.
The gene expression study was conducted using quantitative reverse transcription-PCR, and serum level expression was studied using enzyme linked immunosorbent assay.
Finally, statistical analysis was performed using Jamovi software.
Results
In the present study, the mean age of schizophrenia cases was found to be 31.
5 (±10.
4) years.
Among the cases, the majority (45.
3%, n = 34) were aged 20–29 years.
Results revealed that NOTCH1 and NOTCH4 expression were significantly reduced in schizophrenia cases compared with healthy controls, both in mRNA and serum protein levels.
Further, NOTCH4 expression was significantly reduced in those cases with a chronic mental illness, compared with those without chronic past mental illness.
Conclusion
The findings showed downregulation of NOTCH1 and NOTCH4 in schizophrenia.
Moreover, significant reduction of NOTCH4 gene expression in cases with persistent mental illness, highlighting its possible role in the pathophysiology of the disease.
Related Results
Shikonin supresses hepatocellular carcinoma by inhibiting JAG1/Notch1/uPA Signaling
Shikonin supresses hepatocellular carcinoma by inhibiting JAG1/Notch1/uPA Signaling
BackgroundShikonin, a bioactive naphthoquinone from Arnebiae Radix, exhibits hepatoprotective properties and anti-coagulation effects via inhibiting urokinase-type plasminogen acti...
Abstract PO-073: Inactivation of Notch4 attenuated pancreatic tumorigenesis in mice
Abstract PO-073: Inactivation of Notch4 attenuated pancreatic tumorigenesis in mice
Abstract
Expression of the Notch family of receptors are often upregulated in pancreatic ductal adenocarcinoma (PDAC), however, the functional impacts of the Notch s...
PF581 FUNCTIONAL HIGH‐THROUGHPUT SCREENING FOR IDENTIFICATION OF NOTCH1 DOWNSTREAM EFFECTORS AS NOVEL THERAPEUTIC TARGETS IN MULTIPLE MYELOMA
PF581 FUNCTIONAL HIGH‐THROUGHPUT SCREENING FOR IDENTIFICATION OF NOTCH1 DOWNSTREAM EFFECTORS AS NOVEL THERAPEUTIC TARGETS IN MULTIPLE MYELOMA
Background:Intrinsic and acquired drug resistance of multiple myeloma (MM) cells often cause disease progression in MM patients. Therefore, the identification of novel drug targets...
Small Subclones Harboring NOTCH1, SF3B1 or BIRC3 Mutations Are Clinically Irrelevant in Chronic Lymphocytic Leukemia
Small Subclones Harboring NOTCH1, SF3B1 or BIRC3 Mutations Are Clinically Irrelevant in Chronic Lymphocytic Leukemia
Abstract
Introduction. Ultra-deep next generation sequencing (NGS) allows sensitive detection of mutations and estimation of their clonal abundance in tumor cell pop...
Acquired Notch1 Mutations in Murine Precursor-T Leukemia/Lymphoma Models.
Acquired Notch1 Mutations in Murine Precursor-T Leukemia/Lymphoma Models.
Abstract
NOTCH1 has been implicated in hematopoiesis, T-cell differentiation, and the pathogenesis of precursor T-cell lymphoblastic leukemia/lymphoma (pre-T LBL). A...
Sirt1 Is a Novel Therapeutic Target in T-ALL
Sirt1 Is a Novel Therapeutic Target in T-ALL
Abstract
T-cell Acute Lymphoblastic Leukemia (T-ALL) is an aggressive hematological malignancy that affects both children and adults. Still, 20%-50% of patients show...
Data from Activated Notch1 Induces Lung Adenomas in Mice and Cooperates with Myc in the Generation of Lung Adenocarcinoma
Data from Activated Notch1 Induces Lung Adenomas in Mice and Cooperates with Myc in the Generation of Lung Adenocarcinoma
<div>Abstract<p><i>Notch1</i> encodes the canonical member of the mammalian Notch receptor family. Activating lesions frequently affect <i>Notch1</...
Data from Activated Notch1 Induces Lung Adenomas in Mice and Cooperates with Myc in the Generation of Lung Adenocarcinoma
Data from Activated Notch1 Induces Lung Adenomas in Mice and Cooperates with Myc in the Generation of Lung Adenocarcinoma
<div>Abstract<p><i>Notch1</i> encodes the canonical member of the mammalian Notch receptor family. Activating lesions frequently affect <i>Notch1</...

